Currently out of the existing stock ratings of Yanan Zhu, 33 are a BUY (80.49%), 8 are a HOLD (19.51%).

Yanan Zhu

Work Performance Price Targets & Ratings Chart

Analyst Yanan Zhu works at WELLS FARGO with a stock forecast success ratio of 41.78% fulfilled within 59.27 days on average.

Yanan Zhu’s has documented 83 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 20-Feb-2024.

Wall Street Analyst Yanan Zhu

Analyst best performing recommendations are on AGLE (AEGLEA BIO THERAPEUTICS).
The best stock recommendation documented was for AGLE (AEGLEA BIO THERAPEUTICS) at 10/28/2022. The price target of $37.5 was fulfilled within 13 days with a profit of $14.5 (63.04%) receiving and performance score of 48.49.

Average potential price target upside

ARGX argenx NV ADR EDIT Editas Medicine RAPT RAPT Therapeutics AVRO AVROBIO BLUE Bluebird bio SGMO Sangamo Therapeutics AGLE Aeglea Bio Therapeutics AGTC Applied Genetic TSHA Taysha Gene Therapies  BEAM Beam Therapeutics  NTLA Intellia Therapeutics AFMD Affimed NV AUTL Autolus Therapeutics Ltd FATE Fate Therapeutics IOVA Iovance Biotherapeutics RNA Avidity Biosciences 

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

478

$71.99 (17.73%)

609

4 days ago

7/10 (70%)

$85.77 (21.87%)

169

Buy

560

$153.99 (37.93%)

478

2 months 6 days ago

3/4 (75%)

$104.52 (22.95%)

316

Buy

641

$234.99 (57.88%)

603

2 months 12 days ago

5/7 (71.43%)

$188.37 (41.62%)

259

Buy

560

$153.99 (37.93%)

534.76

2 months 19 days ago

8/9 (88.89%)

$100.43 (21.85%)

227

Buy

586

$179.99 (44.33%)

607

2 months 25 days ago

13/17 (76.47%)

$135.39 (30.05%)

116

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yanan Zhu is most bullish on?

Potential upside of $35.96 has been obtained for RNA (AVIDITY BIOSCIENCES )

Which stock is Yanan Zhu is most reserved on?

Potential downside of -$1.96 has been obtained for FATE (FATE THERAPEUTICS)

What Year was the first public recommendation made by Yanan Zhu?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?